
Treating Heart Valve Disease
CroíValve is an early-stage medical device company developing a novel transcatheter device to repair the tricuspid valve. Its DUO™ System is a catheter-based coaptation device designed to treat tricuspid regurgitation by working in tandem with the native valve, preserving native valve function while restoring coaptation. The company has completed first-in-human implantations and is advancing clinical trials to address a significant unmet need in structural heart disease.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account